Phase II Marker Lesion Study With Intravesical Instillation of Apaziquone for Superficial Bladder Cancer: Toxicity and Marker Response - Concepedia

Concepedia

Publication | Closed Access

Phase II Marker Lesion Study With Intravesical Instillation of Apaziquone for Superficial Bladder Cancer: Toxicity and Marker Response

71

Citations

17

References

2006

Year

Antoine G. van der Heijden, Paula M.J. Moonen, Erik B. Cornel, H. Vergunst, Theo M. de Reijke, E. Boven, Evert J. Barten, Rajiv Puri, C.K. van Kalken, J. Alfred Witjes

The Journal of Urology

Abstract

The histological complete response rate after 6 consecutive instillations of apaziquone in patients with superficial bladder cancer was 67% (95% CI 51 to 80). Local side effects were comparable to side effects due to other chemotherapy instillations.

References

	Year	Citations

Page 1